Gene Transfer of the Na⁺,K⁺-ATPase β1 Subunit Using Electroporation Increases Lung Liquid Clearance

Abstract

The development of nonviral methods for efficient gene transfer to the lung is highly desired for the treatment of several pulmonary diseases. We have developed a noninvasive procedure using electroporation to transfer genes to the lungs of rats. Purified plasmid (100-600 microg) was delivered to the lungs of anesthetized rats through an endotracheal tube, and a series of square-wave pulses were delivered via electrodes placed on the chest. Relatively uniform gene expression was observed in multiple cell types and layers throughout the lung, including airway and alveolar epithelial cells, airway smooth muscle cells, and vascular endothelial cells, and this finding was dose- and pulse length-dependent. Most important, no inflammatory response was detected. To demonstrate efficacy of this approach, the beta1 subunit of the Na(+),K(+)-ATPase was transferred to the lungs of rats with or without electroporation, and 3 days later, alveolar fluid clearance was measured. Animals electroporated with the beta1 subunit plasmid showed a twofold increase in alveolar fluid clearance and Na(+),K(+)-ATPase activity as compared with animals receiving all other plasmids, with or without electroporation. These results demonstrate that electroporation is an effective method to increase clearance by introducing therapeutic genes (Na(+),K(+)-ATPase) into the rat lung.

The Intrinsic Apoptotic Pathway Is Required for Lipopolysaccharide-Induced Lung Endothelial Cell Death

“…Our results support a role for Bid in this model. Lung injury can also be induced by the direct instillation of LPS into the trachea, a model of pneumonia-induced acute lung injury (33). Our results do not show a role for Bid in this model.…”

Lung NF-κB Activation and Neutrophil Recruitment Require IL-1 and TNF Receptor Signaling during Pneumococcal Pneumonia

“…Lung cells were transfected with intratracheally instilled plasmids by transthoracic electroporation (26,39). Using plasmids containing a transgene for GFP, a small fraction of left lung lobe cells were transfected, primarily in the distal parenchyma and closer to the chest wall than the heart (data not shown).…”

Featured Article: Electroporation-mediated gene delivery of surfactant protein B (SP-B) restores expression and improves survival in mouse model of SP-B deficiency

“…[10][11][12]32 The group of transgenic mice treated with either pUbC-hSPB or pCMV-hSPB had improved survival, strong protein expression, improved histology, and a higher percentage Compound SP-B transgenic mice (n ¼ 5) were either maintained on doxycycline or were taken off doxycycline and 100 mg of each plasmid (or no DNA) was delivered to the lungs by electroporation as in Figure 1. Four days later, lungs were removed from animals and portions were homogenized for quantitation of myeloperoxidase activity and normalized to total cell protein (mean AE st.…”

“…Most importantly, the approach causes little to no inflammation and is extremely well tolerated, even in animals with existing lung injury. [10][11][12][13][14] In the present study, we evaluated this approach to deliver SP-B-expressing plasmids to the lungs to restore SP-B production in a compound knockout mouse model of SP-B deficiency. The mouse model uses mice that have been genetically engineered to have both copies of their SP-B gene knocked out but carry an additional tetracycline-inducible copy of the SP-B gene.…”